Vanguard Group Inc. Invests $25.90 Million in Grail, Inc. (NASDAQ:GRAL)

Vanguard Group Inc. acquired a new stake in Grail, Inc. (NASDAQ:GRAL - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,451,095 shares of the company's stock, valued at approximately $25,902,000. Vanguard Group Inc. owned about 4.32% of Grail as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Crcm LP purchased a new position in Grail in the 4th quarter worth about $65,061,000. Primecap Management Co. CA bought a new position in Grail in the 4th quarter worth about $37,118,000. Bank of New York Mellon Corp purchased a new position in shares of Grail during the fourth quarter worth approximately $6,262,000. TCW Group Inc. bought a new stake in shares of Grail during the fourth quarter valued at approximately $5,095,000. Finally, abrdn plc purchased a new stake in shares of Grail in the 4th quarter worth $3,768,000.

Grail Stock Performance

NASDAQ:GRAL traded up $0.50 during trading hours on Friday, reaching $27.00. The company's stock had a trading volume of 642,745 shares, compared to its average volume of 1,221,381. The stock has a 50 day moving average price of $32.83 and a two-hundred day moving average price of $23.64. Grail, Inc. has a 12 month low of $12.33 and a 12 month high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million during the quarter, compared to analysts' expectations of $35.33 million. On average, sell-side analysts predict that Grail, Inc. will post -15.15 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Morgan Stanley increased their target price on shares of Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a report on Tuesday, March 18th.

Insider Transactions at Grail

In other Grail news, CEO Robert P. Ragusa sold 7,625 shares of Grail stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.21, for a total value of $237,976.25. Following the transaction, the chief executive officer now directly owns 828,662 shares of the company's stock, valued at approximately $25,862,541.02. The trade was a 0.91 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Joshua J. Ofman sold 2,109 shares of the stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the sale, the president now owns 559,673 shares of the company's stock, valued at approximately $17,461,797.60. This represents a 0.38 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,550 shares of company stock valued at $360,436 in the last 90 days.

Grail Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.